NJF Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Bioptimus is an AI-first biotech company developing a universal AI foundation model that connects biology across scales, from molecules and cells to tissues and whole organisms, to support biomedical research and innovation.
AI & Machine LearningBiotechDigital HealthHealthtechParis, FR
Eric Durand(Founder)inFelipe Llinares-López(Co-founder & VP of AI)inRodolphe Jenatton(Co-founder & CTO)inZelda Mariet(Co-founder & VP of Research)inJean-Philippe Vert(Co-founder & CEO)inDavid Cahané(Co-founder & General Manager)
Co-investorsAndera PartnersCathay InnovationFELIX CAPITALFrstHeadlineHeadline Growth Management, LLC+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.